Table 2.
Group | IC50 | RI | P |
---|---|---|---|
A549 | 22,387.2 ± 0.6 | ||
A549 + TGF-β | 144,727.0 ± 1.3 | 11.50 | <0.01 |
A549/Docetaxel | 112,201.8 ± 1.2 | 8.91 | <0.01 |
Survival rates of NSCLC cells to anticancer drugs were evaluated by MTT assay. Data were represented as mean ± SD of three independent experiments.